NCT07588542

Brief Summary

The use of custom-created apps, neuropsychological testing, and clinical assessments will be evaluated as tools for determining the appropriateness of PACU discharge to home.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for not_applicable

Timeline
71mo left

Started May 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
May 2026Apr 2032

First Submitted

Initial submission to the registry

March 20, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 14, 2026

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2031

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2032

Last Updated

May 14, 2026

Status Verified

May 1, 2026

Enrollment Period

4.9 years

First QC Date

March 20, 2026

Last Update Submit

May 8, 2026

Conditions

Patient DischargeNeurocognitionBaseline

Outcome Measures

Primary Outcomes (1)

  • Standardized neuropsychiatric testing WAIS SCWT SPWT TOPJ

    comparison of results to baseline measurements of these four validated neuropsychiatric assessments

    24 hours

Secondary Outcomes (2)

  • Memory App

    24 hours

  • Flight Path App

    24 hours

Study Arms (1)

Neuro Assessment Group

EXPERIMENTAL
Diagnostic Test: custom-created apps, neuropsychological testing, and clinical assessments

Interventions

custom-created apps, neuropsychological testing, and clinical assessmentsDIAGNOSTIC_TEST

This study's interventions will include a brief neuropsychological assessment, including pre-operative baseline and post-operative repeat assessment. Additional assessments of memory and coordination using two custom apps and standard clinical assessments will also be conducted at each timepoint

Neuro Assessment Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The individuals will be identified from the operating room (OR) schedule and approached in the pre-operative area (or earlier, when possible).
  • Adult patients (18 years or older) listed for surgery and a planned 23-hour admission will be eligible for enrollment in this study.
  • Subjects must be fluent in English and not have confounding sensory or neurological limitations to participation

You may not qualify if:

  • Members of vulnerable populations or adults unable to consent will be included in this study.
  • Subjects that do not speak English
  • Subjects with neurological limirations

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Illinois Chicago

Chicago, Illinois, 60612, United States

Location

Central Study Contacts

Alexandra Barabanova

CONTACT

312-355-5377barabano@uic.edu

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Department Head Ronald F Albrecht Professor of Anesthesiology; Physician/Surgeon; Chief of Service Department of Anesthesiology

Study Record Dates

First Submitted

March 20, 2026

First Posted

May 14, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

April 1, 2031

Study Completion (Estimated)

April 1, 2032

Last Updated

May 14, 2026

Record last verified: 2026-05

Locations

US(1)